Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

The National Pharmaceutical Pricing Authority (NPPA) has requested data on prices to retailers and annual turnover from ...

Continued pricing pressures from governments and patient groups are driving small molecule CDMOs to focus on reducing the ...

Puducherry's pharma sector sees 15% annual growth, seeks investments for production expansion, facing competition from Tindivanam Pharma Cluster.

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.

The drug Enoxaparin is used for anti-coagulation once there is clot formation in any part of the body. More commonly, it’s ...

INCY has delivered a good performance in the past year on positive data readouts and encouraging pipeline progress. We believe there is room for further growth at current levels.

The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...

Sudarshan and Emerge inked a three-year R&D partnership agreement. The joint venture is expected to begin operations in 2025 ...

Charles River and Akron Bio have announced the integration of the latter’s CSS liquid cytokines into the former's Cell ...

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

Sanofi SNY announced that the phase III IRAKLIA study, which evaluated a fixed-dose subcutaneous (SC) formulation of its ...